Your browser doesn't support javascript.
Severity of COVID-19 after Vaccination among Hemodialysis Patients: An Observational Cohort Study.
Ashby, Damien R; Caplin, Ben; Corbett, Richard W; Asgari, Elham; Kumar, Nicola; Sarnowski, Alexander; Hull, Richard; Makanjuola, David; Cole, Nicholas; Chen, Jian; Nyberg, Sofia; McCafferty, Kieran; Zaman, Faryal; Cairns, Hugh; Sharpe, Claire; Bramham, Kate; Motallebzadeh, Reza; Anwari, Kashif Jamil; Salama, Alan D; Banerjee, Debasish.
  • Ashby DR; Renal and Transplant Centre, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom damien.ashby@nhs.net.
  • Caplin B; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Corbett RW; Department of Renal Medicine, University College London, London, United Kingdom.
  • Asgari E; Renal and Transplant Centre, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Kumar N; Kidney Services, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Sarnowski A; Kidney Services, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Hull R; Renal and Transplantation, St. George's University Hospitals NHS Foundation Trust, London, United Kingdom.
  • Makanjuola D; Renal and Transplantation, St. George's University Hospitals NHS Foundation Trust, London, United Kingdom.
  • Cole N; South West Thames Renal and Transplantation Unit, Epsom and St. Helier University Hospitals NHS Trust, London, United Kingdom.
  • Chen J; South West Thames Renal and Transplantation Unit, Epsom and St. Helier University Hospitals NHS Trust, London, United Kingdom.
  • Nyberg S; Renal Service, Barts Health NHS Trust, London, United Kingdom.
  • McCafferty K; Renal Service, Barts Health NHS Trust, London, United Kingdom.
  • Zaman F; Renal Service, Barts Health NHS Trust, London, United Kingdom.
  • Cairns H; Department of Renal Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Sharpe C; Department of Renal Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Bramham K; Department of Renal Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Motallebzadeh R; Department of Renal Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Anwari KJ; Renal Medicine, Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Salama AD; Renal Medicine, Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Banerjee D; Department of Renal Medicine, University College London, London, United Kingdom.
Clin J Am Soc Nephrol ; 17(6): 843-850, 2022 06.
Article in English | MEDLINE | ID: covidwho-1875315
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Patients receiving hemodialysis are at high risk from coronavirus disease 2019 (COVID-19) and demonstrate impaired immune responses to vaccines. There have been several descriptions of their immunologic responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, but few studies have described the clinical efficacy of vaccination in patients on hemodialysis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS In a multicenter observational study of the London hemodialysis population undergoing surveillance PCR testing during the period of vaccine rollout with BNT162b2 and AZD1222, all of those positive for SARS-CoV-2 were identified. Clinical outcomes were analyzed according to predictor variables, including vaccination status, using a mixed effects logistic regression model. Risk of infection was analyzed in a subgroup of the base population using a Cox proportional hazards model with vaccination status as a time-varying covariate.

RESULTS:

SARS-CoV-2 infection was identified in 1323 patients of different ethnicities (Asian/other, 30%; Black, 38%; and White, 32%), including 1047 (79%) unvaccinated, 86 (7%) after first-dose vaccination, and 190 (14%) after second-dose vaccination. The majority of patients had a mild course; however, 515 (39%) were hospitalized, and 172 (13%) died. Older age, diabetes, and immune suppression were associated with greater illness severity. In regression models adjusted for age, comorbidity, and time period, prior two-dose vaccination was associated with a 75% (95% confidence interval, 56 to 86) lower risk of admission and 88% (95% confidence interval, 70 to 95) fewer deaths compared with unvaccinated patients. No loss of protection was seen in patients over 65 years or with increasing time since vaccination, and no difference was seen between vaccine types.

CONCLUSIONS:

These data demonstrate a substantially lower risk of severe COVID-19 after vaccination in patients on dialysis who become infected with SARS-CoV-2.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Renal Dialysis / COVID-19 / BNT162 Vaccine / ChAdOx1 nCoV-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: Clin J Am Soc Nephrol Journal subject: Nephrology Year: 2022 Document Type: Article Affiliation country: CJN.16621221

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Renal Dialysis / COVID-19 / BNT162 Vaccine / ChAdOx1 nCoV-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: Clin J Am Soc Nephrol Journal subject: Nephrology Year: 2022 Document Type: Article Affiliation country: CJN.16621221